Electron beam fragmentation of bacterial polysaccharides as a method of producing oligosaccharides for the preparation of conjugate vaccines

FEMS Microbiology Letters

Volumn 174, Issue 2, 1999, Pages 255-263

  Pawlowski, Andrzej ^a   Svenson, Stefan B ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Irradiation; Saccharide protein conjugate; Vaccine

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; EPITOPE; PNEUMOCOCCUS VACCINE;

ANTIGENICITY; ARTICLE; BACTERIUM CONJUGATION; CONJUGATION; DEPOLYMERIZATION; DRUG DEVELOPMENT; ELECTRON BEAM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; POLYSACCHARIDES, BACTERIAL; RABBITS; RADIATION, IONIZING; SONICATION; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

BACTERIA (MICROORGANISMS);

EID: 0032961606     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(99)00152-4     Document Type: Article

References (42)

1. Moxon, E.R. and Kroll, J.S. (1990) The role of bacterial polysaccharide capsules as virulence factors. Curr. Topics Microbiol. Immunol. 150, 65-85.
2. Verheul, A.F., Snippe, H. and Poolman, J.T. (1993) Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol. Rev. 57, 34-49.
3. Jann, K. and Jann, B. (1987) Polysaccharide antigens of Escherichia coll Rev. Infect. Dis. 9 (Suppl. 5), S517-S526.
4. Goldberg, J.B. and Pier, G.B. (1996) Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. Trends Microbiol. 4, 490-494.
5. Musher, D.M., Johnson Jr., B. and Watson, D.A. (1990) Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect. Immun. 58, 3871-3876.
6. Douglas, R.M., Paton, J.C., Duncan, S.J. and Hansman, D.J. (1983) Antibody responses to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 148, 131-137.
7. Avery, O.T. and Goebel, W.F. (1929) Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-protein antigens. J. Exp. Med. 50, 533-550.
8. Svenson, S.B. and Lindberg, A.A. (1977) Oligosaccharide-protein conjugate: a novel approach for making Salmonella O-antigen immunogens. FEMS Microbiol. Lett. 1, 145-148.
9. Jörbeck, H.J., Svenson, S.B. and Lindberg, A.A. (1981) Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis. Infect. Immun. 32, 497-502.
10. Adams, W.G., Deaver, K.A., Cochi, S.L., Plikaytis, B.D., Zell, E.R., Broome, C.V. and Wenger, J.D. (1993) Decline of childhood Haemophilus influenzae type b disease in the Hib vaccine era. J. Am. Med. Assoc. 269, 221-226.
11. Fattom, A., Shiloach, J., Bryla, D., Fitzgerald, D., Pastan, I., Karakawa, W.W., Robbins, J.B. and Schneerson, R. (1992) Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid hydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate. Infect. Immun. 60, 584-589.
12. Taylor, D.N., Trofa, A.C., Sadoff, J., Chu, C., Bryla, D., Shiloah, J., Cohen, D., Ashkenazi, S., Lerman, Y., Egan, W., Schneerson, R. and Robbins, J.B. (1993) Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect. Immun. 61, 3678-3687.
13. Svenson, S.B. and Lindberg, A.A. (1979) Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers. J. Immunol. Methods 25, 323-335.
14. Anderson, P.W., Pichichero, M.E., Stein, E.C., Porcell, S., Betts, R.F., Connuck, D.M., Korones, D., Insel, R.A., Zahradnik, J.M. and Eby, R. (1989) Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein CRM 197. J. Immunol. 142, 2464-2468.
15. Pawlowski, A., Källenius, G. and Svenson, S.B. (1999) A new method of non-crosslinking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines. Vaccine (in press).
16. 197. Infect. Immun. 39, 233-238.
17. Anderson, P.W., Pichichero, M.E., Insel, R.A., Betts, R., Eby, R. and Smith, D.H. (1986) Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming of the human infants. J. Immunol. 137, 1181-1186.
18. Wang, Y., Hollingsworth, R.I. and Kasper, D. (1998) Ozonolysis for selectively depolymerizing polysaccharides containing beta-D-aldosidic linkages. Proc. Natl. Acad. Sci. USA 95, 6584-6589.
19. Wessels, M.R., Munoz, A., and Kasper, D.L. (1987) A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide. Proc. Natl. Acad. Sci. USA 84, 9170-9174.
20. Szu, S.C., Zon, G., Schneerson, R. and Robbins, J.B. (1986) Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process. Carbohydr. Res. 152, 7-20.
21. Martin, D.G., Jarvis, F.G. and Milner, K.C. (1967) Physico-chemical and biological properties of sonically treated Vi antigen. J. Bacteriol. 94, 1411-1416.
22. Kubo, K., Nakamura, T., Takagaki, K., Yoshida, Y. and Endo, M. (1993) Depolymerization of hyaluronan by sonication. Glycoconj. J. 10, 435-439.
23. Matsumura, G., Herp, A. and Pigman, W. (1966) Depolymerization of hyaluronic acid by autooxidants and radiations. Radiat. Res. 28, 735-752.
24. McNeil, I.D., Wiebkin, O.W., Cleland, L.G. and Vernon-Roberts, B. (1986) The generation of reducing ends by exposure of hyaluronic acid to oxygen derived free radicals. Agents Actions Suppl. 18, 95-101.
25. 60Co gamma-irradiation on chondromucoprotein. Int. J. Radiat. Biol. 32, 351-359.
26. Jeske, W., Iqbal, O., Gonnela, S., Boveri, G., Torri, G., De Ambrosi, L. and Fareed, J. (1995) Pharmacologic profile of a low-molecular-mass heparin depolymerized by gamma-irradiation. Semin. Thromb. Hemost. 21, 201-211.
27. Miller, J.H., Fedoronko, D.A., Mass, B.D., Myint, M. and Kempner, E.S. (1998) Radiation effects on the native structure of proteins: fragmentation without dissociation. Arch. Biochem. Biophys. 352, 281-287.
28. Rydberg, B. (1996) Clusters of DNA damage induced by ionizing radiation: formation of short DNA fragments. II. Experimental detection. Radiat. Res. 145, 200-209.
29. Hausberger, A.G., Kenley, R.A. and DeLuca, P.P. (1995) Gamma irradiation effects on molecular mass and in vitro degradation of poly(D,L-lactide-co-glycolide) microparticles. Pharm. Res. 12, 851-856.
30. El Sabbagh, M., Galanos, C., Bertok, L., Fust, Gy. and Ludritz, O. (1982) Effect of ionizing radiation on chemical and biological properties of Salmonella minnesota R595 lipopolysaccharide. Acta Microbiol. Acad. Sci. Hung. 29, 255-261.
31. Csako, G., Suba, E.A., Tsai, C.M., Mocca, L.F. and Elin, R.J. (1987) Dose-dependent changes in the antigenicity of bacterial endotoxin exposed to ionizing radiation. J. Clin. Lab. Immunol. 24, 193-198.
32. 60Co gamma irradiation. Acta Microbiol. Hung. 35, 301-305.
33. Kalin, M. (1998) Pneumococcal serotypes and their clinical relevance. Thorax 53, 159-162.
34. Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A. and Smith, F. (1956) Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-356.
35. Park, J.K. and Johnson, M.J. (1949) A submicrodetermination of glucose. J. Biol. Chem. 181, 149-151.
36. Laferrière, C.A., Sood, R.K., de Muys, J.M., Michon, F. and Jennings, H.J. (1997) The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity. Vaccine 15, 179-186.
37. Steinhoff, M.C., Edwards, K., Keyserling, H., Thorns, M.L., Johnson, C., Madore, D. and Hogerman, D. (1994) A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr. Infect. Dis. J. 13, 368-372.
38. de Velasco, E.A., Verheul, A.F.M., Veeneman, G.H., Gomes, L.J.F., van Boom, J.H., Verhoef, J. and Snippe, H. (1993) Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide. Vaccine 11, 1429-1436.
39. Daum, R.S., Hogerman, D., Rennels, M.B., Bewley, K., Malinoski, F., Rothstein, E., Reisinger, K., Block, S., Keyserling, H. and Steinhoff, M. (1997) Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines. J. Infect. Dis. 176, 445-455.
40. Seppälä, I. and Mäkelä, O. (1989) Antigenicity of dextran-protein conjugates in mice: effect of molecular mass of the carbohydrate and comparison of two modes of coupling. J. Immunol. 143, 1259-1264.
41. NOV. J. Exp. Med. 168, 699.
42. Wessels, M.R. and Kasper, D.L. (1989) Antibody recognition of the type 14 pneumococcal capsule: evidence for a conformational epitope in a neutral polysaccharide. J. Exp. Med. 169, 2121-2131.